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Introduction
Recent studies have demonstrated a relationship
between C-reactive protein (CRP), a sensitive marker
of systemic inflammation and the pathogenesis of ath-
erosclerosis [1–6]. Elevated plasma concentration of
CRP is associated with an increased risk of coronary
artery disease, including stroke, myocardial infarction
(MI) and peripheral vascular disease [1–7]. However,
the biologic mechanism underlying this relationship is
unknown and remains to be determined.
Adipose tissue is not only a storage tissue for fat,
but it also secretes a variety of products that can exert
both local and systemic effects, including leptin, tumor
necrosis factor-α (TNF-α) and interleukin-6 (IL-6) [8].
Elevation in serum concentrations of IL-6, a powerful
inducer of inflammatory reaction, causes low-grade
systemic inflammatory reaction with elevated acute
phase reactants, such as CRP [1]. Plasma CRP levels
are not only strongly associated with body mass index
(BMI) [9], but also with obesity-related diseases, includ-
ing insulin resistance, diabetes mellitus, polycystic ovarian
syndrome and hyperlipidemia [10–13].
The prevalence of obesity and obesity-related dis-
eases has increased dramatically in recent years, and
has become a serious public health problem. Using the
definition for Taiwanese population, the prevalence of
overweight (BMI ≥ 24 and BMI < 27 kg/m2) and obesity
(BMI ≥ 27 kg/m2) in 1993–1996 were 22.9% and
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10.5% for men and 20.3% and 13.2% for women,
respectively [14]. Several studies have suggested that a
moderate increase in BMI makes Asians more prone to
insulin resistance and related diseases [15,16], and
CRP has a potential role in the risk assessment of obesity-
related comorbidity [5]. However, there is currently no
such data available in Taiwanese women. We therefore
evaluated the relationship between plasma CRP levels
with obesity, insulin resistance and metabolic syndrome
in Taiwanese women.
Materials and Methods
Study subjects
A cross-sectional study was conducted between March
2003 and February 2005 in the Women’s Weight
Control Clinic at Taiwan Adventist Hospital. The study
was approved by the institutional research board. Infor-
mation was obtained on patient history and symptoms
of coronary heart disease, endocrine disease and smok-
ing. Patients suffering from any acute infection or any
chronic systemic disease (such as heart disease, chronic
renal disease, thyroid disease, etc.) at the time of exam-
ination, as well as current cigarette smoking, were
excluded from the present study. However, women with
hypertension, elevated glucose levels, impaired fasting
glucose and dyslipidemia were not excluded, because
these conditions were thought to be related to obesity.
Collected data included age, body weight (BW), body
height (BH), waist circumference, hip circumference,
BMI, systolic blood pressure (SBP), diastolic blood pres-
sure (DBP), serum levels of CRP, fasting glucose levels,
fasting insulin levels, low-density lipoprotein cholesterol
(LDL-C), high-density lipoprotein cholesterol (HDL-C)
and triglycerides (TG). A homeostasis model assessment
(HOMA) was used to evaluate insulin resistance as
described by Matthews et al [6]. Insulin resistance was
defined as HOMA ≥ 3.8.
The measurements for anthropometric indices were
carried out at the Physical Examination Center, Taiwan
Adventist Hospital, by an internist. Overweight was
defined as BMI ≥ 24 kg/m2 and < 27 kg/m2, and obe-
sity as BMI ≥ 27 kg/m2 [14].
Laboratory measurements
Blood samples were obtained after an overnight fasting
period of 8 hours. Levels of fasting blood glucose, TG,
HDL-C and LDL-C were measured using commercial
kits on an automated analyzer (Synchron CX9; Beckman
Coulter Co., Fullerton, CA, USA). Insulin levels were also
determined using commercial kits on an automa-
ted analyzer (Access Immunoassay System; Beckman
Coulter Co.). The mean of three separate readings of
insulin levels taken within 15 minutes was used for
analysis. CRP concentration was measured by a solid-
phase, chemiluminescent immunometric assay (Immulite
2000; Diagnostic Product Corp., Los Angeles, CA, USA)
with a sensitivity of 0.01 mg/dL. Log of fasting glucose
levels was used for analysis due to a skewness of > 2 in
the distribution of fasting glucose levels.
Statistical analysis
Relationships between CRP and the various parameters
were investigated using Pearson’s correlation analysis.
In order to investigate the effects of metabolic syn-
drome on serum CRP, the Wilcoxon rank-sum test was
used to compare the serum levels of CRP in women who
had metabolic syndrome and in those without meta-
bolic syndrome. Similar comparison was also performed
to look at the impact of insulin resistance on serum
CRP levels.
Forward stepwise regression procedure [17] was
used to find a “best” subset of predictor variables for
CRP. CRP was designated as a dependent variable, and
all the variables that were significantly correlated with
CRP in Pearson’s correlation analysis were used as inde-
pendent variables to calculate the relative contribu-
tions of each variable. The following variables were
considered for the model: BW, waist circumference, hip
circumference, BMI, log of fasting glucose levels, fasting
insulin levels and HOMA. A value of p < 0.05 was con-
sidered to be statistically significant. Only variables
that had p < 0.05 were considered to be outcome vari-
ables in the final fitted model. Odds ratios and 95%
confidence intervals of the development of metabolic
syndrome and insulin resistance when a CRP level
≥ 0.6 were also calculated.
Results
A total of 59 cases were included in this study. The
basic characteristics of the study population are listed
in the Table. BMI ranged from 24.3 to 57.5 kg/m2; 69%
(41/59) of subjects had BMI ≥ 27. CRP varied from
0.04 to 2.18 mg/dL, with six subjects having a CRP level
> 1.0 mg/dL. Waist–hip ratio (WHR) ranged from 0.71
to 1.03. HOMA varied from 0.02 to 8.52; 20 women
(33%) had insulin resistance with HOMA ≥ 3.8. Fasting
serum insulin levels ranged from 0.01 to 32.3 IU/mL.
The results of Pearson’s correlation between CRP
and dependent variables are also shown in the Table.
CRP was significantly positively correlated with anthro-
pometric indices, including BW (r = 0.68, p < 0.01), BMI
(r = 0.67, p < 0.01), waist circumference (r = 0.63,
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p < 0.01), hip circumference (r = 0.72, p < 0.01), but
not WHR. Variables associated with insulin resistance,
including log of fasting glucose, fasting insulin and
HOMA, were also significantly correlated with CRP
levels. There were no associations between CRP and
blood pressure, cholesterol and TG. The relationships
of CRP with hip circumference and HOMA are pre-
sented using scatter plots in the Figure.
Women with BMI ≥ 27 kg/m2 had significantly higher
CRP (0.62 ± 0.23 vs. 0.28 ± 0.05 mg/dL, p < 0.001),
HOMA (3.66 ± 4.35 vs. 1.56 ± 1.65, p < 0.001) and fast-
ing insulin (14.1 ± 50.9 vs. 6.65 ± 30.9 IU/mL, p < 0.001)
than women with BMI between 24 and 27 kg/m2.
Women with insulin resistance had higher CRP than
women without insulin resistance (0.76 ± 0.59 vs. 0.40 ±
0.33 mg/dL).
In order to find a best subset of predictor variables
for CRP, all variables that were significantly correlated
with CRP, including BW, waist circumference, hip 
circumference, BMI, log of fasting glucose, fasting
insulin and HOMA, were used as independent variables
for forward stepwise regression. Forward stepwise regres-
sion showed that the best predictor variable for CRP
was hip circumference, with CRP = −2.66 ± 0.03 × hip
circumference (r2 = 0.52, p < 0.001). Hip circumference
explained 52% of the variance of CRP.
Discussion
In the present study, we have shown that plasma CRP,
a sensitive marker of inflammation that has been pre-
viously reported to be associated with cardiovascular
disease, is positively correlated with obesity, insulin
resistance and metabolic syndrome in Taiwanese women.
To date, most studies have been conducted in Western
populations, with higher BMI and lower fat percentage
than Chinese or other Asian groups [18]. This study is
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Figure. Relationships between C-reactive protein and (A) hip circumference; and (B) homeostasis model assessment
(HOMA); presented as scatter plots.
the first to report such associations in adult women 
in Taiwan.
Previous studies have shown that elevation in plasma
CRP may be associated with obesity and cardiovascu-
lar disease [1,11]. The association between CRP levels
and BMI [19] has been previously demonstrated.
Another interesting but less investigated issue is the
relationship between CRP and fasting insulin levels.
Previous reports support the association between CRP
and insulin resistance [11]. It has been suggested that
a chronic inflammatory process might be an impor-
tant contributor to the glucose intolerance. Elevated
levels of CRP and IL-6 predict the subsequent develop-
ment of type II diabetes [10,12]. Festa et al showed that
chronic subclinical inflammation was part of the insulin
resistance syndrome and CRP was independently related
to insulin sensitivity [10].
The present study has shown a strong association
between CRP levels and anthropometric indices, includ-
ing BW, waist circumference, hip circumference and
BMI, but not WHR. The present study also showed
strong associations between CRP and fasting glucose,
fasting insulin and HOMA. In addition, strong correla-
tions between BW, BMI, waist circumference, hip cir-
cumference, serum insulin and HOMA were noted.
Women with insulin resistance had higher CRP levels.
Furthermore, women with higher CRP levels also had a
higher incidence of insulin resistance.
However, the relationship between CRP and insulin
is controversial. Because obesity is intimately related
to an increase in fasting insulin level, it is possible that
the relationship between CRP and insulin is indirect. The
relationship between fasting insulin level and CRP could
present an association produced by a co-related variable,
such as obesity. Obesity-related insulin resistance may
be, at least in part, a chronic inflammatory disease initi-
ated in the adipose tissue. A study performed in pre-
menopausal women showed that obesity, but not insulin
resistance, is the major determinant in serum cardio-
vascular risk markers [10].
Therefore, forward stepwise regression was used in
the present study to find the “best” predictor(s) for CRP.
It showed that hip circumference was the best predic-
tor for CRP levels. The corollary would be that obesity
was the most important determinant in serum cardio-
vascular risk markers. This result is compatible with
that of Manolio et al [20].
The correlation between serum CRP levels and meta-
bolic syndrome was also demonstrated by previous
studies. In a study by Lee et al [21], significant positive
correlations were identified between CRP and BMI,
waist circumference, TG, blood pressure and glucose,
with a significant negative correlation between CRP and
HDL. Rutter et al [22] demonstrated that elevated
CRP levels are related with the presence of metabolic
syndrome, especially in women. The present study has
demonstrated the significant positive correlations
between CRP and three out of the five components of
metabolic syndrome, including waist circumference, DBP
and fasting glucose levels. However, blood pressure
and TG were not included in the “best” predictor(s) for
CRP. This means that the correlation between CRP and
metabolic syndrome may be due to the strong correla-
tion of CRP with obesity, rather than with other com-
ponents of the metabolic syndrome.
It is notable that even a mild increase in serum CRP
levels may be related to a marked increase in the inci-
dence of insulin resistance and metabolic syndrome.
In the study group, a CRP level ≥ 0.6 mg/dL had a
3.56 times increased risk for metabolic syndrome, and
a 3.88 times increased risk for insulin resistance, which
indicated a marked increase in the risk of cardiovascu-
lar disease and type II diabetes.
Several potential limitations affect the interpreta-
tion of the present study results. The most important
was the relatively small sample size, which made the
results of statistical analysis inconsistent. Larger scale
experiment is required to obtain further conclusions.
Secondly, most of the subjects in our study were over-
weight or obese; the results might not be generalizable to
women of normal weight, or to women of other races.
In conclusion, this pilot cross-sectional study has
demonstrated associations between CRP, a marker of
systemic inflammation, and obesity, insulin resistance
and metabolic syndrome in overweight or obese women
in Taiwan. The correlations between CRP and metabolic
syndrome and between CRP and insulin resistance are
attributed to their strong correlations with obesity. 
A mildly subclinical increase in serum CRP is related to a
marked increase in the risk of cardiovascular disease
and type II diabetes in overweight or obese women.
References
1. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V.
Inflammation, obesity, stress and coronary heart disease: is
interleukin-6 the link? Atherosclerosis 2000;148:209–14.
2. Blake GJ, Ridker PM. Novel clinical markers of vascular wall
inflammation. Circ Res 2001;89:763–71.
3. Lemieux I, Pascot A, Prud’Homme D, et al. Elevated C-reactive
protein: another component of the atherothrombotic
profile of abdominal obesity. Arterioscler Thromb Vasc Biol
2001;21:961–7.
4. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein
adds to the predictive value of total and HDL cholesterol in
determining risk of first myocardial infarction. Circulation
1998;97:2007–11.
Taiwanese J Obstet Gynecol • September 2006 • Vol 45 • No 3 219
Hip Circumference and Plasma CRP Levels
5. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH.
Prospective study of C-reactive protein and the risk of
future cardiovascular events among apparently healthy
women. Circulation 1998;98:731–3.
6. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D,
Turner R. Homeostasis model assessment: insulin resis-
tance and B-cell function from fasting plasma glucose and
insulin concentrations in man. Diabetologia 1985;28:412–9.
7. Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of 
C-reactive protein and coronary heart disease in the MRFIT
nested case-control study. Multiple Risk Factor Intervention
Trial. Am J Epidemiol 1996;44:537–47.
8. Hauner H. Secretory factors from human adipose tissue
and their functional role. Proc Nutr Soc 2005;64:163–9.
9. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris
TB. Elevated C-reactive protein levels in overweight and
obese adults. JAMA 1999;282:2131–5.
10. Festa A, D’Agostino R, Howard G, Mykkanen L, Tracy RP,
Haffner SM. Chronic subclinical inflammation as part of the
insulin resistance syndrome. The Insulin Resistance Atheros-
clerosis Study (IRAS). Circulation 2000;102:42–7.
11. Yudkin JS, Stehouwer CDA, Emesis JJ, Coppack SW. C-reactive
protein in healthy subjects: associations with obesity, insulin
resistance, and endothelial dysfunction: a potential role for
cytokines originating from adipose tissue? Arterioscler Thromb
Vasc Biol 1999;19:972–8.
12. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. 
C-reactive protein, interleukin 6, and risk of developing
type 2 diabetes mellitus. JAMA 2001;286:327–34.
13. Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N.
Low grade chronic inflammation in women with polycystic
ovarian syndrome. J Clin Endocrinol Metab 2001;86:
2453–5.
14. Lin YC, Yen LL, Chen SY, et al. Prevalence of overweight and
obesity and its associated factors: findings from National
Nutrition and Health Survey in Taiwan, 1993–1996. Prev
Med 2003;37:233–41.
15. Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE.
Body composition, leptin, and insulin resistance in Asian
Indian Men. J Clin Endocrinol Metab 1999;84:137–44.
16. Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy
SM. Relationship between generalized and upper body obesity
to insulin resistance in Asian Indian men. J Clin Endocrinol
Metab 1999;84:137–44.
17. Neter J, Kutner MH, Nachtsheim CJ, Wasserman W. Applied
Linear Statistical Models, 4th edition. USA: Times Mirror
Higher Education Group, 2000:348–53.
18. Deurenberg-Yap M, Schmidt G, van Staveren WA,
Deurenberg P. The paradox of low body mass index and high
body fat percentage among Chinese, Malays and Indians in
Singapore. Int J Obes Relat Metab Disord 2000;24:1011–7.
19. Saijo Y, Kiyota N, Kawasaki Y, Miyazaki Y, Kashimura J,
Fukuda M, Kishi R. Relationship between C-reactive pro-
tein and visceral adipose tissue in healthy Japanese sub-
jects. Diabetes Obes Metab 2004;6:249–58.
20. Manolio TA, Savage PJ, Burke GL, et al. Correlates of fast-
ing insulin levels in young adults: the CARDIA study. J Clin
Epidemiol 1991;44:571–8.
21. Lee WY, Park JS, Noh SY, et al. C-reactive protein concen-
trations are related to insulin resistance and metabolic syn-
drome as defined by the ATP III report. Int J Cardiol 2004;
97:101–6.
22. Rutter MK, Meigs JB, Sullivan LM, D’Agostino RB Sr,
Wilson PW. C-reactive protein, the metabolic syndrome,
and prediction of cardiovascular events in the Framingham
Offspring Study. Circulation 2004;110:380–5.
Taiwanese J Obstet Gynecol • September 2006 • Vol 45 • No 3220
H.J. Jou, et al
